The Latin America, Middle East and Africa Cell Viability Assays Market should witness market growth of 15.5% CAGR during the forecast period (2022-2028).
ATP (Adenosine triphosphate) cell viability is an assay used to measure cell viability since only viable cells can make ATP. Reagents with the CellTiter-Glo luminescent cell viability assay that contains detergent, luciferin substrate, and stabilized luciferase can be used to measure ATP. The detergent lyses viable cells, discharging ATP into the medium.
Luciferin is used by luciferase to create luminescence in the presence of ATP, which can be detected in a few minutes using a luminometer. The CellTiter-Glo 2.0 Assay is given as a single solution that decreases the reagent preparation time and allows storing it at room temperature, making implementation easier.
As these ATP assays don’t require lengthy incubation times to convert a substrate into a colored product, they usually work faster than other methods. In addition, they have wide linearity and excellent sensitivity, making them very suitable for high throughput applications with low cell numbers. They also have reduced risks of artifacts than other methods.
The Dubai Health Authority (DHA), a governing entity, is responsible for monitoring the Health System in the Emirates of Dubai. DHA was established in 2007 by the Prime Minister of Dubai. The Health Regulation Sector (HRS) of the DHA is responsible for licensing, monitoring, and regulating health facilities and the professionals related to healthcare.
The Brazil market dominated the LAMEA Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $58.2 million by 2028. The Argentina market is experiencing a CAGR of 16.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 15.2% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
ATP (Adenosine triphosphate) cell viability is an assay used to measure cell viability since only viable cells can make ATP. Reagents with the CellTiter-Glo luminescent cell viability assay that contains detergent, luciferin substrate, and stabilized luciferase can be used to measure ATP. The detergent lyses viable cells, discharging ATP into the medium.
Luciferin is used by luciferase to create luminescence in the presence of ATP, which can be detected in a few minutes using a luminometer. The CellTiter-Glo 2.0 Assay is given as a single solution that decreases the reagent preparation time and allows storing it at room temperature, making implementation easier.
As these ATP assays don’t require lengthy incubation times to convert a substrate into a colored product, they usually work faster than other methods. In addition, they have wide linearity and excellent sensitivity, making them very suitable for high throughput applications with low cell numbers. They also have reduced risks of artifacts than other methods.
The Dubai Health Authority (DHA), a governing entity, is responsible for monitoring the Health System in the Emirates of Dubai. DHA was established in 2007 by the Prime Minister of Dubai. The Health Regulation Sector (HRS) of the DHA is responsible for licensing, monitoring, and regulating health facilities and the professionals related to healthcare.
The Brazil market dominated the LAMEA Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $58.2 million by 2028. The Argentina market is experiencing a CAGR of 16.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 15.2% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
Scope of the Study
By Product
- Consumables
- Reagents & Assay Kits
- Luminometric Assays
- Dye Exclusion Assays
- Colorimetric Assays
- Fluorometric Assays
- Microplates
- Reagents & Assay Kits
- Instruments
- Spectrophotometer
- Microscopy
- Cell Imaging & Analysis System
- Flow Cytometry
- Others
By End-user
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Diagnostic Labs
By Application
- Stem Cell Research
- Drug Discovery & Development
- Diagnostics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Cell Viability Assays Market by Product
Chapter 5. LAMEA Cell Viability Assays Market by End-user
Chapter 6. LAMEA Cell Viability Assays Market by Application
Chapter 7. LAMEA Cell Viability Assays Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Methodology
LOADING...
Related Reports
From
Cell Viability Assays Market by Product, Application, End User, and by Region - Global Forecast to 2022-2033
- Report
- 200 Pages
- Region: Global
From
From
From
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
